Showing 31-40 of 9116 results for "".
Turmeric Tonic as a Treatment in Scalp Psoriasis
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/turmeric-tonic-as-a-treatment-in-scalp-psoriasis/24460/Peter Lio, MD, leads this analysis of a study on the effectiveness of a topical turmeric preparation for mild-to-moderate scalp psoriasis. While the trial results indicated a reduction in Psoriasis Area & Severity Index (PASI) scores and improved quality of life for participants using the turmerMelanoma Vaccine Shows Promise
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-vaccine-shows-promise/23345/Phase 2b data suggest a personalized vaccine may improve disease-free survival.Which Probiotic for Which Disease? Part 2
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-2/23596/The conclusion of this 2-part series reviews the research for probiotics in the management of AD, acne, and psoriasis.Teledermatology Use during the COVID-19 Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/teledermatology-use-during-the-covid-19-pandemic/23769/Despite challenges, the future of teledermatology is promising.Vitamin D and Psoriasis
https://practicaldermatology.com/topics/practice-management/vitamin-d-and-psoriasis/21470/New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown.New Treatment Algorithms for Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-treatment-algorithms-for-actinic-keratoses/18812/Gary Goldenberg, MD reviews the literature showing why all actinic keratoses (AKs) need to be treated and why it's important to treat the field and not just the visible lesions. He shares his evidence-based, time-sequential therapy approach to combining a destructive modality with field therapy to pTolerability of JAK Inhibitors Used in Dermatology
https://practicaldermatology.com/series/jak-inhibitors-in-practice/tolerability-of-jak-inhibitors-used-in-dermatology/20126/Although safety and tolerability are often intertwined, they are distinct considerations. Topical and oral JAKs used in dermatology today seem to offer good tolerability. Adelaide A. Hebert, MD and Matthew Zirwas, MD discuss potential side effects, management, and monitoring in pediatric and adult pHistopathologic Assessment of Atypical Pigmented Lesions: Financial and Diagnostic Considerations
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histopathologic-assessment-of-atypical-pigmented-lesions-financial-and-diagnostic-considerations/21335/Taking prospective deeper sections may prove more cost-efficient in the long-term.Science of Skincare Summit 2024: Ethical Relationships with Industry
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-ethical-relationships-with-industry/29455/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about building relationships with industry that maintain proper independence and compliance with pPsoriasis, Biologics, and Cardiovascular Disease: The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/psoriasis-biologics-and-cardiovascular-disease-the-heart-of-the-matter/23215/A relationship between increased cardiovascular events in patients with psoriasis has implications for management of this chronic disease.